RBC Positive on Alkermes (ALKS): 'we would be buyers into strength and upcoming NT2 data'
Tweet Send to a Friend
RBC Capital analyst Leonid Timashev reiterated an Outperform rating and $47.00 price target on Alkermes (NASDAQ: ALKS).The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
